Personnel Information

写真a

Yokota Takanori


Job title

Professor

Mail Address

The inquiry by e-mail is 《here

Graduating School 【 display / non-display

  • Tokyo Medical and Dental University, Faculty of Medicine, 1984, Graduated

Degree 【 display / non-display

  • Medical Doctor, Tokyo Medical and Dental University

Campus Career 【 display / non-display

  • 2014.08
    -
    2018.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Neurology and Neurological Science, Professor
  • 2018.04
    -
    2020.05
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Neurology and Neurological Science, Professor
  • 2020.06
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Cognitive and Behavioral Medicine, Neurology and Neurological Science, Professor

Research Areas 【 display / non-display

  • Neurology

 

Published Papers & Misc 【 display / non-display

  • Jinbing Xie, Daniel Gonzalez-Carter, Theofilus A Tockary, Noriko Nakamura, Yonger Xue, Makoto Nakakido, Hiroki Akiba, Anjaneyulu Dirisala, Xueying Liu, Kazuko Toh, Tao Yang, Zengtao Wang, Shigeto Fukushima, Junjie Li, Sabina Quader, Kouhei Tsumoto, Takanori Yokota, Yasutaka Anraku, Kazunori Kataoka. Dual-Sensitive Nanomicelles Enhancing Systemic Delivery of Therapeutically Active Antibodies Specifically into the Brain. ACS Nano. 2020.05; ( PubMed, DOI )

  • Masahiro Ohara, Takaaki Hattori, Takanori Yokota. Progressive supranuclear palsy often develops idiopathic normal pressure hydrocephalus-like MRI features. Eur. J. Neurol.. 2020.05; ( PubMed, DOI )

  • Ryo Iwase, Taro Ishiguro, Kyohei Fujita, Satoru Ishibashi, Takanori Yokota. Dupilumab for Atopic Dermatitis, a Possible Risk Factor of Juvenile Ischemic Stroke: A Case Report. J Stroke Cerebrovasc Dis. 2020.04; 104763. ( PubMed, DOI )

  • Kosei Hirata, Takaaki Hattori, Satoko Kina, Qingmeng Chen, Masahiro Ohara, Takanori Yokota. Striatal Dopamine Denervation Impairs Gait Automaticity in Drug-Naïve Parkinson's Disease Patients. Mov. Disord.. 2020.03; ( PubMed, DOI )

  • Tai Otani, Takashi Irioka, Susumu Igarashi, Kimihiko Kaneko, Toshiyuki Takahashi, Takanori Yokota. Self-remitting cerebral cortical encephalitis associated with myelin oligodendrocyte glycoprotein antibody mimicking acute viral encephalitis: A case report. Mult Scler Relat Disord. 2020.02; 41 102033. ( PubMed, DOI )

display all >>

Books etc 【 display / non-display

  • Sekiguchi T, Abe K, Ohkubo T, Kanouchi T, Yokota T. Annual Review Neurology 2014. Chugai-igaku-sha Co.,Ltd, 2014.01 Pathomechanisms of the onset and progression of amyotrophic lateral sclerosis (ALS) (ISBN : 978-4-498-22814-6)

Conference Activities & Talks 【 display / non-display

  • Takanori Yokota. New Stage of DNA/RNA Heteroduplex Oligonucleotide. Asia TIDES:Oligonucleotide & Peptide Therapeutics 2020.02.24 kyoto

  • Kotaro Yoshioka. Heteroduplex-Oligonucleotides for Highly Efficient Silencing of microRNA through a Novel intracellular Mechanism. 2019 Oligonucleotides Meeting 2019.11.16 Munich

  • Takanori Yokota. Systemically Administered DNA/RNA Heteroduplex Oligonucleotides That Can Efficiently Regulate CNS Genes*. TIDES Europe2019:Oligonucleotide &Peptide Therapeutics 2019.11.13 Amsterdam

  • Amano A,Sanjo N,Nakakido M,Tsumoto K,Matsubara E,Furukawa F,Nishida Y,Saito T,Saido T,Yokota T,. Quantitative evaluation of Aβ oligomer in mouse brain using dot blot method. 第38回日本認知症学会学術集会 2019.11.07 新宿

  • Yokota T. BBB-penetrating DNA/RNA heteroduplex oligonucleotide efficiently regulating CNS gene.. Tokyo Medical and Dental University-Taipei Medical University Joint Symposium on Medical Innovation 2019.10.05 Taipei

display all >>

Patents 【 display / non-display

  • CHIMERIC DOUBLE-STRANDED NUCLEIC ACID

    Patent Number: 10329567

  • CHIMERIC DOUBLE-STRANDED NUCLEIC ACID

    Patent Number: 10337006

  • CHIMERIC SINGLE-STRANDED ANTISENSE POLYNUCLEOTIDES AND DOUBLE-STRANDED ANTISENSE AGENT

    Patent Number: 2961841

  • CARRIER FOR USE IN DELIVERING DRUG, CONJUGATE, COMPOSITION COMPRISING SAME, AND METHOD FOR ADMINISTRATING SAME

    Patent Number: 9,937,263

  • CARRIER FOR USE IN DELIVERING DRUG, CONJUGATE, COMPOSITION COMPRISING SAME, AND METHOD FOR ADMINISTRATING SAME

    Patent Number: 201480063806.3

display all >>

Others 【 display / non-display

  • 2018.06

    Journal of Controlled Release